Abstract
It has been almost two decades since the discovery that tricyclic antidepressants and monoamine oxidase (MAO) inhibitors were clinically effective in the treatment of depression. In spite of intensive investigations, neither the mo lecular mechanisms whereby antidepressants operate nor the etiology of this disease is well understood. The knowledge that reserpine, which depletes monoamine stores,1,2 can induce a depressed mood 3 has stimulated speculation on a causal relationship between a defect in monoaminergic transmission and endogenous depression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brodie, B. B., Pletsher, A., and Shore, P. A., 1956, Science 123:992–994.
Holzbauer, M., and Vogt, M., 1956, J. Neurochem. 1:8–11.
Brodie, B. B., and Shore, P. A., 1957, Ann. N.Y., Acad. Sci. 66:631–638.
Carlsson, A., Corrodi, H., Fuxe, K., and Hokfelt, T., 1969, Eur. J. Pharmacol. 5:357–366.
Carlsson, A., Johanson, J., Lindquist, M., and Fuxe, K., 1959, Brain Res. 12:456–460.
Glowinski, J., and Axelord, J., 1964, Nature 204:1318–1319.
Ross, S. B., and Renyl, A. L., 1967, Eur. J. Pharmacol. 2:181–186.
Thomas, P. C., and Jones, P. B., 1977, J. Pharm. Pharmacol. 29:562–563.
Hamberger, B., and Tuck, J. R., 1973, Eur. J. Clin. Pharmacol. 5:229–235.
Bunney, W. E., and Davis, J. M., 1965, Arch. Gen. Psychiatry 13:483–494.
Schildkraut, J. J., 1965, Am. J. Psychiatry 122:509–522.
Post, R. M., and Goodwin, F. K., and 1978, Handbook of Psychopharmacology ,Volume 13 (L. L. Iversen, Iversen, S. D., and S. H. Snyder, eds.), Raven Press, New York, pp. 1235–1247.
Van Praag, H. M., 1978, Acta Psychiatr. Scand. 57:389–404.
Garver, D. L., and Davis, J. M., 1979, Life Sci. 24:383–391.
Kostowski, W., 1981, Science 6:314–317.
Murphy, D. L., Campbell, I., and Costa, J. L., 1978, Psychopharmacology (M. A. Lipton, A. DiMascio, and K. K. Killam, eds.), Raven Press, New York, pp. 1235–1247.
Leonard, B. E., 1974, Psychopharmacologia 36:221–236.
Goodlet, I., Mireylees, S. E., and Sugrue, M. F., 1977, Br. J. Pharmacol. 61:307–313.
Rosloff, B. N., and Davis, J. M., 1974, Psychopharmacologia 40:53–64.
Ferris, R. M., Maxwell, R. A., Cooper, R. A., and Soroko, F. E., 1982, Advances in Bio chemical Psychopharmacology ,Volume 31 (E. Costa and G. Racagni, eds.), Raven Press, New York, pp. 277–286.
Hertting, G., Axelrod, J., and Whitby, L., 1961, J. Pharmacol. Exp. Ther. 134:146–153.
Nielsen, M., 1975, J. Pharmacol. 27:206–208.
Roffman, M., Kling, M. A., Cassens, G., Orsulak, P. J., Reigle, T. G., and Schildkraut, J. J., 1977, Psychopharmacol. Commun. 1:195–206.
Bareggi, S. R., Markey, K., and Genovese, E., 1978, Eur. J. Pharmacol. 50:301–308.
Tang, S. W., Helmeste, D. M., and Stancer, H. C., 1978, Naunyn Schmiedebergs Arch. Pharmacol. 305:207–211.
Neff, N. H., and Costa, E., 1967, Antidepressant Drugs (S. Garattini and M. N. H. Dukes, eds.), Excerpta Medica, Amsterdam, pp. 28–34.
Schildkraut, J. J., Roffman, M., Orsulak, P. J., Schatzberg, A. F., Kling, M. A., and Reigle, T. G., 1976, Pharmakopsychiatrie 9:193–202.
Sugrue, M. F., 1980, Life Sci. 26:423–429.
Schildkraut, J. J., Winokur, A., Draskoczy, P. R., and Hensle, J. H., 1971, Am. J. Psychiatry 127:72–79.
Van Wijk, M., Meisch, J. J., and Korf, J., 1977, Psychopharmacology 55:217–223.
Corrodi, H., and Fuxe, K., 1969, Pharmacology 7:56–59.
Meek, J. L., and Werdinius, B., 1970, J. Pharm. Pharmacol. 22:141–143.
Goodlet, I., and Sugrue, M. F., 1974, Eur. J. Pharmacol. 29:241–248.
Marcro, E. J., and Meek, J. L., 1979, Naunyn Schmiedebergs Arch. Pharmacol. 306:75–79.
Nielsen, M., and Braestrup, C., 1977, Naunyn Schmiedbergs Arch. Pharmacol. 300:87–92.
Raiteri, M., Angelini, F., and Bertollini, A., 1976, J. Pharm. Pharmacol. 28:483–488.
Kafoe, W. F., DeRidder, J. J., and Leonard, B. E., 1976, Biochem. Pharmacol. 25:2455–2460.
Van Riezen, H., 1972, Arch. Int. Pharmacodyn. 198:256–269.
Maj, J., Sowinska, H., Baran, L., Gancarczyk, L., and Rawlow, A., 1978, Psychopharmacology 59:79–84.
Rosloff, B. N., and Davis, J. M., 1978, Psychopharmacology 56:335–341.
Sherman, A., 1979, Psychopharmacol. Commun. 3:1–5.
Sanghvi, I., and Gershon, S., 1975, Biochem. Pharmacol. 24:2103–2104.
Ross, S. B., Ogren, S. O., and Renyi, A. L., 1976, Acta Pharmacol. Toxicol. 39:152–166.
Fuller, R. W., Perry, K. W., and Molloy, B. B., 1975, J. Pharmacol. Exp. Ther. 193:796–803.
Wong, D. T., Bymaster, F. P., Horng, J. S., and Malloy, B. B., 1975, J. Pharmacol. Exp. Ther. 193:804–811.
Fuxe, K., Ogren, S.-O., and Agnati, L. F., 1979, Neurosci. Lett. 13:307–312.
Hwang, E. C., and Van Woert, M. H., 1980, Psychopharmacol. Commun. 4:161–167.
Langer, S. Z., 1974, Biochem. Pharmacol. 23:1793–1800.
Berthelsen, S., and Pettinger, W. A., 1977, Life Sci. 21:595–606.
Starke, K., and Langer, S. Z., 1979, Presynaptic Receptors (S. Z. Langer, K. Starke, and M. L. Dubocovich, eds.), Pergamon Press, Oxford, pp. 1–3.
U’Prichard, D. C., Bechtel, W. D., Rouot, B. M., and Snyder, S. H., 1979, Mol. Pharmacol. 16:47–60.
Langer, S. Z., 1977, Br. J. Pharmacol. 60:481–497.
Starke, K., Taube, H. D., and Borowski, E., 1977, Biochem. Pharmacol. 26:259–268.
Westfall, T. C., 1977, Physiol. Rev. 57:659–728.
Anden, N.-E., Grabowska, M., and Strombom, U., 1976, Naunyn Schmiedebergs Arch. Phar macol. 292:43–52.
Delini-Stula, A., Baumann, P., and Buch, O., 1979, Naunyn Schmiedebergs Arch. Pharmacol. 307:115–122.
Crews, F. T., and Smith, C. B., 1978, Science 202:322–324.
McMillen, B. A., Warnack, W., German, D. C., and Shore, P. A., 1980, Eur. J. Pharmacol. 61:239–246.
Sugrue, M. F., 1981, Life Sci. 208:377–384.
Sugrue, M. F., 1981, Pharmacol. Ther. 13:219–249.
Johnson, R. W., Reisine, T., Spotnitz, S., Wiech, N., Ursillo, R., and Yamamura, H. I., 1980, Eur. J. Pharmacol. 67:123–127.
Smith, C. B., Garcia-Sevilla, J., and Hollingsworth, P. J., 1981, Brain Res. 210:413–418.
Tang, S. W., and Seeman, P., 1980, Naunyn Schmiedebergs Arch. Pharmacol. 311:255–261.
Maggi, A., U’Prichard, D. C., and Enna, S. J., 1980, Eur. J. Pharmacol. 61:91–98.
Fludder, J. M., and Leonard, B. E., 1979, Psychopharmacology 64:329–332.
Sugrue, M. F., 1980, Eur. J. Pharmacol. 68:377–380.
Tang, S. W., Helmeste, D. M., and Stancer, H. C., 1979, Can. J. Physiol. Pharmacol. 57:435–437.
Banerjee, S. P., Kung, L. S., Riggi, S. J., and Chanda, S. K., 1977, Nature 268:455–456.
Sarai, K., Frazer, A., Brunswick, D., and Mendels, J., 1978, Biochem. Pharmacol. 27:2179–2181.
Wolfe, B. B., Harden, T. K., Sporn, J. R., and Molinoff, P. B., 1978, J. Pharmacol. Exp. Ther. 207:446–457.
Bergstrom, D. A., and Kellar, K. J., 1979, J. Pharmacol. Exp. Ther. 209:256–261.
Dibner, M. D., and Molinoff, P. B., 1979, J. Pharmacol. Exp. Ther. 210:433–439.
Peroutka, S. J., and Snyder, S. H., 1980, Science 210:88–90.
Sellinger-Barnette, M. M., Mendels, J., and Frazer, A., 1980, Neuropharmacology 19:447–454.
Kinner, W. J., Chuang, D. M., and Costa, E., 1979, Eur. J. Pharmacol. 67:289–294.
Rosenblatt, J. E., Pert, C. B., Tallman, J. F., Pert, A., and Bunney, W. E., Jr., 1979, Brain Res. 160:186–191.
Clement-Jewery, S., 1978, Neuropharmacology 17:779–781.
Minneman, K. P., and Molinoff, P. B., 1980, Biochem. Pharmacol. 29:1317–1323.
Minneman, K. P., Dibner, M. D., Wolfe, B. B., and Molinoff, P. B., 1979, Science 204:866–868.
Weiss, B., Heydorn, W., and Frazer, A., 1982, Advances in Biochemical Psychopharmacology ,Volume 31, Typical and Atypical Antidepressants (E. Costa and G. Racagni, eds.), Raven Press, New York, pp. 37–54.
Chuang, D. M., and Costa, E., 1979, Proc. Natl. Acad. Sci. U.S.A. 76:3024–3028.
Chuang, D. M., Kinnier, W. J., Farber, L., and Costa, F., 1980, Mol. Pharmacol. 18:348–355.
Chuang, D. M., 1981, J. Biol. Chem. 256:8291–8293.
Chuang, D. M., 1982, Biochem. Biophys. Res. Commun. 105:1466–1472.
Bergstrom, D. A., and Kellar, K. J., 1979, Nature 278:464–466.
Gillespie, D. D., Manier, D. H., and Sulser, F., 1979, psychopharmacol. Commun. 3:191–195.
Pandey, G. N., Heinze, W. J., Brown, B. D., and Davis, J. M., 1979, Nature 280:234–235.
Schultz, J. E., Siggins, G. R., Shocker, F. W., Turck, M., and Bloom, F. E., 1981, J. Phar macol. Exp. Ther. 216:28–38.
Sulser, F., 1982, Advances in Biochemical Psychopharmacology ,Volume 31, Typical and Atypical Antidepressants (E. Costa and G. Racagni, eds.), Raven Press, New York, pp. 1–20.
Sulser, F., 1981, Towards Understanding Receptors (J. W. Lamble, ed.), Elsevier/North-Holland, Amsterdam, pp. 99–104.
Paul, S. M., and Crews, F. T., 1980, Eur. J. Pharmacol. 62:349–350.
Sethy, V. H., and Harris, D. W., 1981, Eur. J. Pharmacol. 75:53–56.
Vetulani, J., and Sulser, F., 1975, Nature 257:495–496.
Vetulani, J., Stawarz, R. J., Dingell, J. V., and Sulser, F., 1976, Naunyn Schmiedebergs Arch. Pharmacol. 293:109–114.
Mishra, R., Janowsky, A., and Sulser, F., 1980, Neuropharmacology 19:983–987.
Mishra, R., Janowsky, A., and Sulser, F., 1979, Eur. J. Pharmacol. 60:379–382.
Schweitzer, J. W., Schwartz, R., and Friedhoff, A. J., 1979, J. Neurochem. 33:377–379.
Janowsky, A., Steranka, L. R., Gillespie, D. D., and Sulser, F., 1982, J. Neurochem. 39:290–292.
Rehavi, M., Ramot, O., Yavetz, B., and Sokolovsky, M., 1980, Brain Res. 294:443–453.
U’Prichard, D. C., Greenberg, D. A., Sheehan, P. P., and Snyder, S. H., 1978, Science 199:197–198.
Rehavi, M., Maayani, S., and Sokolovsky, M., 1977, Biochem. Pharmacol. 26:1559–1567.
Reisine, T., U’Prichard, D., Wiech, N., Ursillo, R., and Yamamura, H., 1980, Brain Res. 188:587–592.
Smith, C. B., Garcia-Sevilla, J. A., and Hollingsworth, P. J., 1981, Brain Res. 210:413–418.
Enjalbert, A., Bourgoin, S., Hamon, M., Adrien, J., and Bockaert, J., 1978, Mol. Pharmacol. 14:2–10.
Fillion, G., Rousselle, J. C., Beaudoin, D., Pradelles, P., Goiny, M., Dray, F., and Jacob, J., 1979, Life Sci. 24:1815–1822.
Barbaccia, M. L., Brunello, N., Chuang, D. M., and Costa, E., 1983,7. Neurochem. 40:1671–1679.
Savage, D. D., Frazer, A., and Mendels, J., 1979, Eur. J. Pharmacol. 58:87–88.
Savage, D. D., Mendels, J., and Frazer, A., 1980, J. Pharmacol. Exp. Ther. 212:259–263.
Peroutka, S. J., and Snyder, S. H., 1979, Mol. Pharmacol. 16:687–689.
Peroutka, S. J., and Snyder, S. H., 1981, J. Pharmacol. Exp. Ther. 216:142–148.
Leysen, J. E., Niemegeers, C. J. E., Van Neuten, J. M., and Laduron, P. M., 1982, Mol. Pharmacol. 21:301–314.
Barbaccia, M. L., Gandolfi, O., Chuang, D. M., and Costa, E., 1983, Neuropharmacology 22:123–126.
Brunello, N., Chuang, D. M., and Costa, E., 1982, Science 215:1112–1115.
Brunello, N., Chuang, D. M., and Costa, E., 1982, Advances in the Bioscience: New Vistas in Depression ,Volume 40 (S. Z. Langer, R. Takahashi, and M. Briley eds.), Pergamon Press, Oxford, New York, pp. 141–145.
Segawa, T., Mizuta, T., and Nomura, Y., 1979, Eur. J. Pharmacol. 58:75–83.
Wirz-Justice, A., Krauchi, K., Lichsteiner, M., and Feer, H., 1978, Life Sci. 23:1249–1254.
Peroutka, S. J., and Snyder, S. H., 1980, J. Pharmacol. Exp. Ther. 215:582–587.
Briley, M., Raisman, R., Arbilla, S., Casadamont, M., and Langer, S. Z., 1982, Eur. J. Pharmacol. 81:309–314.
Zsilla, G., Barbaccia, M. L., Gandolfi, O., Knoll, J., and Costa, E., 1983, Eur. J. Pharmacol. 89:111–117.
Maggi, A., and Enna, S. J., 1980, J. Neurochem. 34:888–892.
Treiser, S., and Kellar, K. J., 1979, Eur. J. Pharmacol. 64:183–185.
Kellar, K. J., Cascio, C. S., Butler, J. A., and Kurtzke, R. H., 1981, Eur. J. Pharmacol. 69:515–518.
Borowski, E., Starke, K., Ehrl, H., and Endo, T., 1977, Neuroscience 2:285–296.
Doxey, J. C., Everitt, J., and Metcalf, G., 1978, Eur. J. Pharmacol. 51:1–10.
Cavero, I., Gomeni, R., LeFevre-Borg, F., and Roach, A. G., 1980, Br. J. Pharmacol. 68:321–332.
Clineschmidt, B. V., Flataker, L. M., Faison, E., and Holmes, R., 1979, Arch. Int. Phar-macodyn. Ther. 242:59–76.
Hall, H., and Ogren, S. O., 1981, Eur. J. Pharmacol. 70:393–407.
Black, J. W., Duncan, W. A. M., Durant, G. J., Ganellin, C. R., and Parson, E. M., 1972, Nature 236:385–390.
Tran, V. T., Lebovitz, R., Toll, L., and Snyder, S. H., 1981, Eur. J. Pharmacol. 70:501–509.
Taylor, J. E., and Richelson, E., 1982, Eur. J. Pharmacol. 78:279–285.
Figge, J., Leonard, P., and Richelson, E., 1979, Eur. J. Pharmacol. 58:479–483.
Richelson, E., 1978, Nature ,274:176–177.
Barbaccia, M. L., Brunello, N., Chuang, D. M., and Costa, E., 1983, Neuropharmacology 22:373–383.
Kanof, P. D., and Greengard, P., 1978, Nature 272:329–333.
Green, J. P., and Maayani, S., 1977, Nature 269:165–166.
Hollister, L. E., 1978, N. Engl. J. Med. 299:1106–1109, 1168–1172.
Bloom, F., Segal, D., Ling, N., and Guillemin, R., 1976, Science 194:630–632.
Biegon, A., and Samuel, D., 1980, Biochem. Pharmacol. 29:460–462.
Costa, E., 1981, Towards Understanding Receptors (J. W. Lamble, ed.), Elsevier/North-Holland, Amsterdam, pp. 176–183.
Squires, R. F., and Braestrup, C., 1977 Nature 266:732–734.
Mohler, H., and Okada, T., 1977, Life Sci. 20:2101–2110.
Massoti, M., Guidotti, A., and Costa, E., 1981, GABA and Benzodiazepine Receptors (E. Costa, G. DiChiara, and G. L. Gressa, eds.), Raven Press, New York, pp. 19–26.
Ebstein, B., Guidotti, A., and Costa, E., 1982, Problems in GABA Research from Brain to Bacteria (Y. Okada and E. Roberts, eds.), Excerpta Medica, Amsterdam, pp. 348–354.
Raisman, R., Briley, M., and Langer, S. Z., 1979, Eur. J. Pharmacol. 54:307–308.
Raisman, R., Briley, M., and Langer, S. Z., 1979, Nature 281:148–150.
Rehavi, M., Paul, S. M., Skolnick, P., and Goodwin, F. K., 1980, Life Sci. 26:2273–2279.
Dumbrille-Ross, A., Tang, S. W., and Coscina, D. V., 1981, Life Sci. 29:2049–2058.
Hirdina, P. D., Elson-Hartman, K., Roberts, D. C. S., and Rappas, B. A., 1981, Eur. J. Pharmacol. 73:375–376.
Briley, M. S., Fillion, G., Beaudoin, D., Fillion, M.-P., and Langer, S. Z., 1980, Eur. J. Pharmacol. 64:191–194.
Briley, M. S., Raisman, R., Sechter, D., Zarifian, E., and Langer, S. Z., 1980, Neurophar macology 19:1209–1210.
Briley, M. S., and Langer, S. Z., 1981, Eur. J. Pharmacol. 72:377–380.
Palkovits, M., Raisman, R., Briley, M., and Langer, S. Z., 1981, Brain Res. 210:493–498.
Kinnier, W. J., Chuang, D. M., Gwynn, G., and Costa, E., 1981, Neuropharmacology 20:411– 419.
Chuang, D. M., Brunello, N., Kinnier, W. J., and Costa, E., 1982, Advances in the Biosciences: New Vistas in Depression ,Volume 40 (S. Z. Langer, R. Takahashi, and M. Briley, eds.), Pergamon Press, Oxford, New York, pp. 133–139.
Briley, M. S., Raisman, R., and Langer, S. Z., 1979, Eur. J. Pharmacol. 58:347–348.
Paul, S. M., Rehavi, M., Skolnick, P., and Goodwin, F. K., 1980, Life Sci. 26:953–959.
Wennogle, L. P., Beer, B., and Meyerson, L. R., 1981, Pharmacol. Biochem. Behav. 15:975–982.
Sette, M., Raisman, R., Briley, M., and Langer, S. Z., 1981, J. Neurochem. 37:40–42.
Paul, S. M., Rehavi, M., Rice, K. C., Ittah, Y., and Skolnick, P., 1981, Life Sci. 28:2753–2760.
Langer, S. Z., Morat, C., Raisman, R., Dubocovich, M. L., and Briley, M., 1980, Science 210:1133–1135.
Rehavi, M., Ittah, Y., Rice, K. C., Skolnick, P., Goodwin, F. K., and Paul, S. M., 1981, Biochem. Biophys. Res. Commun. 99:954–959.
Ahtee, L., Briley, M., Raisman, R., Lebrec, D., and Langer, S. Z., 1982, Life Sci. 29:2323–2329.
Brunello, N., Chuang, D. M., and Costa, E., 1982, Advances in Biochemical Psychopharmacology: Volume 31, Typical and Atypical Antidepressants (E. Costa and G. Racagni, eds.), Raven Press, New York, pp. 179–184.
Mogilnicka, E., Arbilla, S., Depoortere, H., and Langer, S. Z., 1980, Eur. J. Pharmacol. 65:289–292.
Langer, S. Z., Zarifian, E., Briley, M., Raisman, R., and Sechter, D., 1981, Life Sci. 29:211–220.
Briley, M. S., Langer, S. Z., Raisman, R., Sechter, D., and Zarifian, E., 1980, Science 209:303–305.
Paul, S. M., Rehavi, M., Skolnick, P., Ballenger, J. C., and Goodwin, F. K., 1981, Arch. Gen. Psychiatry 38:1315–1317.
Stanley, M., Virgilio, J., and Gershon, S., 1982, Science 216:1337–1339.
Tuomoisto, J., Tukiainen, E., and Ahlfors, U. G., 1979, Psychopharmacology 65:141–147.
Vargaftig, B. B., Coignet, J. L., deVos, C. J., Grijsen, H., and Bonta, I. L., 1971, Eur. J. Pharmacol. 16:336–346.
Whitaker, P. M., and Cross, A. J., 1980, Biochem. Pharmacol. 29:2709–2715.
Dumbrille-Ross, A., Tang, S. W., and Seeman, P., 1980, Eur. J. Pharmacol. 68:395–396.
Brunello, N., Chuang, D. M., and Costa, E., 1982, Eur. J. Pharmacol. 78:383–384.
Mohler, H., Okada, T., and Enna, S. J., 1978, Brain Res. 156:391–395.
Braestrup, C., Nielsen, M., and Squires, F. R., 1979, Life Sci. 24:347–350.
Massotti, M., Alleva, F. R., Balázs, T., and Guidotti, A., 1980, Neuropharmacology 19:951–956.
Rehavi, M., Skolnick, P., Hulihan, B., and Paul, S. M., 1981, Eur. J. Pharmacol. 70:597–599.
Langer, S. Z., Raisman, R., and Briley, M., 1981, Eur. J. Pharmacol. 72:423–424.
Lee, C.-M., and Snyder, S. H., 1981, Proc. Natl. Acad. Sci. U.S.A. 78:5250–5254.
Brunello, N., Barbaccia, M. L., Chuang, D. M., and Costa, E., 1982, Neuropharmacology 21:1145–1149.
Chuang, D. M., Barbaccia, M. L., Brunello, N., and Kinnier, W. J., 1982, Dynamics of Neurotransmission (I. Hanin, ed.), Raven Press, New York (in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chuang, DM., Costa, E. (1984). Recognition Sites for Antidepressant Drugs. In: Lajtha, A. (eds) Handbook of Neurochemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4568-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4568-8_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4570-1
Online ISBN: 978-1-4684-4568-8
eBook Packages: Springer Book Archive